Dr. James (Jim) Woody, CEO of 180 Life Sciences Corp., a newly formed clinical-stage biotech company focused on novel drugs for unmet needs in inflammatory diseases, fibrosis, and pain, discusses three clinical programs using anti-TNF, with the lead program in Phase 2b/3 for Dupuytren’s contracture, a fibrotic disease of the hand.  He previously led the […]

NORTH PLATTE, Neb. — At least 20 patients have been treated with a drug called Aviptadil at Great Plains Health (GPH). This North Platte hospital is the only one in the state to administer this drug. Infectious Disease Physician Eduardo Freitas said his connections with other doctors around the country allowed him to get in […]

The company suggests their experimental COVID-19 vaccine, UB-612, has the features and potential to disrupt the traditional vaccine distribution and supply status quo. COVAXX has announced advanced purchase commitments for more than 140 million doses of its UB-612 vaccine for COVID-19. The public and private agreements, totalling over $2.8 million, are to deliver vaccines in […]